An Expert View from Lindsay Mateo, chief commercial officer at Weave Bio.

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

US pharma giant Pfizer and Japan’s Astellas Pharma today announced positive top-line results from the Phase III EV-303 ...

US generics major Viatris has won US Food and Drug Administration (FDA) approval for iron sucrose injection, USP, an ...

US pharma major Eli Lilly (NYSE: LLY) is partnering with the UK’s Department for Science, Innovation and Technology to fund ...

UK and USA-listed PureTech Health today announced the launch of a new founded entity to be called Celea Therapeutics.

South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...

Eli Lilly has announced positive top-line results from the Phase III BRUIN CLL-314 trial of Jaypirca (pirtobrutinib), a ...

Sweden’s Enzymatica has appointed Sana Alajmovic as its new chief executive (CEO), succeeding Claus Egstrand, who has ...

The US Food and Drug Administration (FDA) has announced the fiscal year 2024 Report on the State of Pharmaceutical Quality ...

US biotech Rezo Therapeutics today announced the appointment of Derek Hicks as its chief executive (CEO). With more than 25 ...

Germany’s Bayer and privately-held Kumquat Biosciences, a US biotech founded by pioneers of the KRAS pathway, have entered into an exclusive global license and collaboration to develop and ...